Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1529222

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1529222

LAMEA Degenerative Disc Disease Treatment Market Size, Share & Trends Analysis Report By Route of Administration, By Drugs, By End Use, By Treatment Type, By Country and Growth Forecast, 2024 - 2031

PUBLISHED:
PAGES: 133 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Multi User License)
USD 1800
PDF (Corporate User License)
USD 2520

Add to Cart

The Latin America, Middle East and Africa Degenerative Disc Disease Treatment Market would witness market growth of 7.1% CAGR during the forecast period (2024-2031).

The Brazil market dominated the LAMEA Degenerative Disc Disease Treatment Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $791.8 million by 2031. The Argentina market is showcasing a CAGR of 7.9% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 6.8% during (2024 - 2031).

Adopting treatments for degenerative disc disease in the healthcare industry is influenced by several factors, including the availability of treatment options, patient preferences, healthcare provider recommendations, advancements in medical technology, and clinical guidelines. Healthcare providers often adhere to guidelines when recommending treatment options, influencing adoption rates for specific physical therapy, medications, and surgical interventions.

Patient preferences, values, and expectations are crucial in adopting DDD treatments. Shared decision-making between patients and healthcare providers allows personalized treatment plans to align with patient goals, lifestyles, and preferences. Patients may opt for conservative treatments initially and progress to more invasive options based on symptom severity and response to therapy.

Increased funding supports recruiting and retaining highly skilled orthopedic surgeons, neurologists, and pain management specialists specializing in spine disorders like DDD. This ensures that patients in the UAE have access to specialized expertise for personalized treatment plans. With a greater healthcare budget, the UAE can afford to invest in minimally invasive surgical techniques for treating DDD. These advanced procedures reduce recovery times, minimize surgical risks, and improve patient outcomes compared to traditional open surgeries. Therefore, the rising healthcare budget and increasing elderly population in the region drive the market's growth.

Based on Route of Administration, the market is segmented into Oral, and Injectable. Based on Drugs, the market is segmented into NSAIDs (Non-Steroidal Anti-Inflammatory Drugs), Acetaminophen, Muscle Relaxants, and Steroids. Based on End Use, the market is segmented into Hospitals, Clinics, and Others. Based on Treatment Type, the market is segmented into Physical Therapy, Occupational Therapy, Special Exercises, Weight Loss Surgery, and Medications.Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

  • Medtronic PLC
  • AstraZeneca PLC
  • Pfizer, Inc.
  • Novartis AG
  • Eli Lilly And Company
  • Spine Wave Inc.
  • B. Braun Melsungen AG (Aesculap, Inc.)
  • DiscGenics, Inc.
  • Spine BioPharma Inc.
  • Stryker Corporation

LAMEA Degenerative Disc Disease Treatment Market Report Segmentation

By Route of Administration

  • Oral
  • Injectable

By Drugs

  • NSAIDs (Non-Steroidal Anti-Inflammatory Drugs)
  • Acetaminophen
  • Muscle Relaxants
  • Steroids

By End Use

  • Hospitals
  • Clinics
  • Others

By Treatment Type

  • Physical Therapy
  • Occupational Therapy
  • Special Exercises
  • Weight Loss Surgery
  • Medications

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 LAMEA Degenerative Disc Disease Treatment Market, by Route of Administration
    • 1.4.2 LAMEA Degenerative Disc Disease Treatment Market, by Drugs
    • 1.4.3 LAMEA Degenerative Disc Disease Treatment Market, by End Use
    • 1.4.4 LAMEA Degenerative Disc Disease Treatment Market, by Treatment Type
    • 1.4.5 LAMEA Degenerative Disc Disease Treatment Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
    • 3.2.3 Market Opportunities
    • 3.2.4 Market Challenges
  • 3.3 Porter Five Forces Analysis

Chapter 4. LAMEA Degenerative Disc Disease Treatment Market by Route of Administration

  • 4.1 LAMEA Oral Market by Country
  • 4.2 LAMEA Injectable Market by Country

Chapter 5. LAMEA Degenerative Disc Disease Treatment Market by Drugs

  • 5.1 LAMEA NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) Market by Country
  • 5.2 LAMEA Acetaminophen Market by Country
  • 5.3 LAMEA Muscle Relaxants Market by Country
  • 5.4 LAMEA Steroids Market by Country

Chapter 6. LAMEA Degenerative Disc Disease Treatment Market by End Use

  • 6.1 LAMEA Hospitals Market by Country
  • 6.2 LAMEA Clinics Market by Country
  • 6.3 LAMEA Others Market by Country

Chapter 7. LAMEA Degenerative Disc Disease Treatment Market by Treatment Type

  • 7.1 LAMEA Physical Therapy Market by Country
  • 7.2 LAMEA Occupational Therapy Market by Country
  • 7.3 LAMEA Special Exercises Market by Country
  • 7.4 LAMEA Weight Loss Surgery Market by Country
  • 7.5 LAMEA Medications Market by Country

Chapter 8. LAMEA Degenerative Disc Disease Treatment Market by Country

  • 8.1 Brazil Degenerative Disc Disease Treatment Market
    • 8.1.1 Brazil Degenerative Disc Disease Treatment Market by Route of Administration
    • 8.1.2 Brazil Degenerative Disc Disease Treatment Market by Drugs
    • 8.1.3 Brazil Degenerative Disc Disease Treatment Market by End Use
    • 8.1.4 Brazil Degenerative Disc Disease Treatment Market by Treatment Type
  • 8.2 Argentina Degenerative Disc Disease Treatment Market
    • 8.2.1 Argentina Degenerative Disc Disease Treatment Market by Route of Administration
    • 8.2.2 Argentina Degenerative Disc Disease Treatment Market by Drugs
    • 8.2.3 Argentina Degenerative Disc Disease Treatment Market by End Use
    • 8.2.4 Argentina Degenerative Disc Disease Treatment Market by Treatment Type
  • 8.3 UAE Degenerative Disc Disease Treatment Market
    • 8.3.1 UAE Degenerative Disc Disease Treatment Market by Route of Administration
    • 8.3.2 UAE Degenerative Disc Disease Treatment Market by Drugs
    • 8.3.3 UAE Degenerative Disc Disease Treatment Market by End Use
    • 8.3.4 UAE Degenerative Disc Disease Treatment Market by Treatment Type
  • 8.4 Saudi Arabia Degenerative Disc Disease Treatment Market
    • 8.4.1 Saudi Arabia Degenerative Disc Disease Treatment Market by Route of Administration
    • 8.4.2 Saudi Arabia Degenerative Disc Disease Treatment Market by Drugs
    • 8.4.3 Saudi Arabia Degenerative Disc Disease Treatment Market by End Use
    • 8.4.4 Saudi Arabia Degenerative Disc Disease Treatment Market by Treatment Type
  • 8.5 South Africa Degenerative Disc Disease Treatment Market
    • 8.5.1 South Africa Degenerative Disc Disease Treatment Market by Route of Administration
    • 8.5.2 South Africa Degenerative Disc Disease Treatment Market by Drugs
    • 8.5.3 South Africa Degenerative Disc Disease Treatment Market by End Use
    • 8.5.4 South Africa Degenerative Disc Disease Treatment Market by Treatment Type
  • 8.6 Nigeria Degenerative Disc Disease Treatment Market
    • 8.6.1 Nigeria Degenerative Disc Disease Treatment Market by Route of Administration
    • 8.6.2 Nigeria Degenerative Disc Disease Treatment Market by Drugs
    • 8.6.3 Nigeria Degenerative Disc Disease Treatment Market by End Use
    • 8.6.4 Nigeria Degenerative Disc Disease Treatment Market by Treatment Type
  • 8.7 Rest of LAMEA Degenerative Disc Disease Treatment Market
    • 8.7.1 Rest of LAMEA Degenerative Disc Disease Treatment Market by Route of Administration
    • 8.7.2 Rest of LAMEA Degenerative Disc Disease Treatment Market by Drugs
    • 8.7.3 Rest of LAMEA Degenerative Disc Disease Treatment Market by End Use
    • 8.7.4 Rest of LAMEA Degenerative Disc Disease Treatment Market by Treatment Type

Chapter 9. Company Profiles

  • 9.1 Medtronic PLC
    • 9.1.1 Company overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Segmental and Regional Analysis
    • 9.1.4 Research & Development Expenses
    • 9.1.5 Recent strategies and developments:
      • 9.1.5.1 Partnerships, Collaborations, and Agreements:
      • 9.1.5.2 Trail and Approvals:
    • 9.1.6 SWOT Analysis
  • 9.2 AstraZeneca PLC
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Regional Analysis
    • 9.2.4 Research & Development Expenses
    • 9.2.5 SWOT Analysis
  • 9.3 Pfizer, Inc.
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Regional & Segmental Analysis
    • 9.3.4 Research & Development Expense
    • 9.3.5 SWOT Analysis
  • 9.4 Novartis AG
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Segmental and Regional Analysis
    • 9.4.4 Research & Development Expense
    • 9.4.5 Recent strategies and developments:
      • 9.4.5.1 Partnerships, Collaborations, and Agreements:
      • 9.4.5.2 Acquisition and Mergers:
    • 9.4.6 SWOT Analysis
  • 9.5 Eli Lilly And Company
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Regional Analysis
    • 9.5.4 Research & Development Expenses
    • 9.5.5 SWOT Analysis
  • 9.6 Spine Wave Inc.
    • 9.6.1 Company Overview
  • 9.7 B. Braun Melsungen AG (Aesculap, Inc.)
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Segmental and Regional Analysis
    • 9.7.4 Research & Development Expenses
    • 9.7.5 SWOT Analysis
  • 9.8 DiscGenics, Inc.
    • 9.8.1 Company Overview
  • 9.9 Spine BioPharma Inc.
    • 9.9.1 Company Overview
  • 9.10. Stryker Corporation
    • 9.10.1 Company Overview
    • 9.10.2 Financial Analysis
    • 9.10.3 Segmental and Regional Analysis
    • 9.10.4 Research & Development Expenses
    • 9.10.5 SWOT Analysis

LIST OF TABLES

  • TABLE 1 LAMEA Degenerative Disc Disease Treatment Market, 2020 - 2023, USD Million
  • TABLE 2 LAMEA Degenerative Disc Disease Treatment Market, 2024 - 2031, USD Million
  • TABLE 3 LAMEA Degenerative Disc Disease Treatment Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 4 LAMEA Degenerative Disc Disease Treatment Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 5 LAMEA Oral Market by Country, 2020 - 2023, USD Million
  • TABLE 6 LAMEA Oral Market by Country, 2024 - 2031, USD Million
  • TABLE 7 LAMEA Injectable Market by Country, 2020 - 2023, USD Million
  • TABLE 8 LAMEA Injectable Market by Country, 2024 - 2031, USD Million
  • TABLE 9 LAMEA Degenerative Disc Disease Treatment Market by Drugs, 2020 - 2023, USD Million
  • TABLE 10 LAMEA Degenerative Disc Disease Treatment Market by Drugs, 2024 - 2031, USD Million
  • TABLE 11 LAMEA NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) Market by Country, 2020 - 2023, USD Million
  • TABLE 12 LAMEA NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) Market by Country, 2024 - 2031, USD Million
  • TABLE 13 LAMEA Acetaminophen Market by Country, 2020 - 2023, USD Million
  • TABLE 14 LAMEA Acetaminophen Market by Country, 2024 - 2031, USD Million
  • TABLE 15 LAMEA Muscle Relaxants Market by Country, 2020 - 2023, USD Million
  • TABLE 16 LAMEA Muscle Relaxants Market by Country, 2024 - 2031, USD Million
  • TABLE 17 LAMEA Steroids Market by Country, 2020 - 2023, USD Million
  • TABLE 18 LAMEA Steroids Market by Country, 2024 - 2031, USD Million
  • TABLE 19 LAMEA Degenerative Disc Disease Treatment Market by End Use, 2020 - 2023, USD Million
  • TABLE 20 LAMEA Degenerative Disc Disease Treatment Market by End Use, 2024 - 2031, USD Million
  • TABLE 21 LAMEA Hospitals Market by Country, 2020 - 2023, USD Million
  • TABLE 22 LAMEA Hospitals Market by Country, 2024 - 2031, USD Million
  • TABLE 23 LAMEA Clinics Market by Country, 2020 - 2023, USD Million
  • TABLE 24 LAMEA Clinics Market by Country, 2024 - 2031, USD Million
  • TABLE 25 LAMEA Others Market by Country, 2020 - 2023, USD Million
  • TABLE 26 LAMEA Others Market by Country, 2024 - 2031, USD Million
  • TABLE 27 LAMEA Degenerative Disc Disease Treatment Market by Treatment Type, 2020 - 2023, USD Million
  • TABLE 28 LAMEA Degenerative Disc Disease Treatment Market by Treatment Type, 2024 - 2031, USD Million
  • TABLE 29 LAMEA Physical Therapy Market by Country, 2020 - 2023, USD Million
  • TABLE 30 LAMEA Physical Therapy Market by Country, 2024 - 2031, USD Million
  • TABLE 31 LAMEA Occupational Therapy Market by Country, 2020 - 2023, USD Million
  • TABLE 32 LAMEA Occupational Therapy Market by Country, 2024 - 2031, USD Million
  • TABLE 33 LAMEA Special Exercises Market by Country, 2020 - 2023, USD Million
  • TABLE 34 LAMEA Special Exercises Market by Country, 2024 - 2031, USD Million
  • TABLE 35 LAMEA Weight Loss Surgery Market by Country, 2020 - 2023, USD Million
  • TABLE 36 LAMEA Weight Loss Surgery Market by Country, 2024 - 2031, USD Million
  • TABLE 37 LAMEA Medications Market by Country, 2020 - 2023, USD Million
  • TABLE 38 LAMEA Medications Market by Country, 2024 - 2031, USD Million
  • TABLE 39 LAMEA Degenerative Disc Disease Treatment Market by Country, 2020 - 2023, USD Million
  • TABLE 40 LAMEA Degenerative Disc Disease Treatment Market by Country, 2024 - 2031, USD Million
  • TABLE 41 Brazil Degenerative Disc Disease Treatment Market, 2020 - 2023, USD Million
  • TABLE 42 Brazil Degenerative Disc Disease Treatment Market, 2024 - 2031, USD Million
  • TABLE 43 Brazil Degenerative Disc Disease Treatment Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 44 Brazil Degenerative Disc Disease Treatment Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 45 Brazil Degenerative Disc Disease Treatment Market by Drugs, 2020 - 2023, USD Million
  • TABLE 46 Brazil Degenerative Disc Disease Treatment Market by Drugs, 2024 - 2031, USD Million
  • TABLE 47 Brazil Degenerative Disc Disease Treatment Market by End Use, 2020 - 2023, USD Million
  • TABLE 48 Brazil Degenerative Disc Disease Treatment Market by End Use, 2024 - 2031, USD Million
  • TABLE 49 Brazil Degenerative Disc Disease Treatment Market by Treatment Type, 2020 - 2023, USD Million
  • TABLE 50 Brazil Degenerative Disc Disease Treatment Market by Treatment Type, 2024 - 2031, USD Million
  • TABLE 51 Argentina Degenerative Disc Disease Treatment Market, 2020 - 2023, USD Million
  • TABLE 52 Argentina Degenerative Disc Disease Treatment Market, 2024 - 2031, USD Million
  • TABLE 53 Argentina Degenerative Disc Disease Treatment Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 54 Argentina Degenerative Disc Disease Treatment Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 55 Argentina Degenerative Disc Disease Treatment Market by Drugs, 2020 - 2023, USD Million
  • TABLE 56 Argentina Degenerative Disc Disease Treatment Market by Drugs, 2024 - 2031, USD Million
  • TABLE 57 Argentina Degenerative Disc Disease Treatment Market by End Use, 2020 - 2023, USD Million
  • TABLE 58 Argentina Degenerative Disc Disease Treatment Market by End Use, 2024 - 2031, USD Million
  • TABLE 59 Argentina Degenerative Disc Disease Treatment Market by Treatment Type, 2020 - 2023, USD Million
  • TABLE 60 Argentina Degenerative Disc Disease Treatment Market by Treatment Type, 2024 - 2031, USD Million
  • TABLE 61 UAE Degenerative Disc Disease Treatment Market, 2020 - 2023, USD Million
  • TABLE 62 UAE Degenerative Disc Disease Treatment Market, 2024 - 2031, USD Million
  • TABLE 63 UAE Degenerative Disc Disease Treatment Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 64 UAE Degenerative Disc Disease Treatment Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 65 UAE Degenerative Disc Disease Treatment Market by Drugs, 2020 - 2023, USD Million
  • TABLE 66 UAE Degenerative Disc Disease Treatment Market by Drugs, 2024 - 2031, USD Million
  • TABLE 67 UAE Degenerative Disc Disease Treatment Market by End Use, 2020 - 2023, USD Million
  • TABLE 68 UAE Degenerative Disc Disease Treatment Market by End Use, 2024 - 2031, USD Million
  • TABLE 69 UAE Degenerative Disc Disease Treatment Market by Treatment Type, 2020 - 2023, USD Million
  • TABLE 70 UAE Degenerative Disc Disease Treatment Market by Treatment Type, 2024 - 2031, USD Million
  • TABLE 71 Saudi Arabia Degenerative Disc Disease Treatment Market, 2020 - 2023, USD Million
  • TABLE 72 Saudi Arabia Degenerative Disc Disease Treatment Market, 2024 - 2031, USD Million
  • TABLE 73 Saudi Arabia Degenerative Disc Disease Treatment Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 74 Saudi Arabia Degenerative Disc Disease Treatment Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 75 Saudi Arabia Degenerative Disc Disease Treatment Market by Drugs, 2020 - 2023, USD Million
  • TABLE 76 Saudi Arabia Degenerative Disc Disease Treatment Market by Drugs, 2024 - 2031, USD Million
  • TABLE 77 Saudi Arabia Degenerative Disc Disease Treatment Market by End Use, 2020 - 2023, USD Million
  • TABLE 78 Saudi Arabia Degenerative Disc Disease Treatment Market by End Use, 2024 - 2031, USD Million
  • TABLE 79 Saudi Arabia Degenerative Disc Disease Treatment Market by Treatment Type, 2020 - 2023, USD Million
  • TABLE 80 Saudi Arabia Degenerative Disc Disease Treatment Market by Treatment Type, 2024 - 2031, USD Million
  • TABLE 81 South Africa Degenerative Disc Disease Treatment Market, 2020 - 2023, USD Million
  • TABLE 82 South Africa Degenerative Disc Disease Treatment Market, 2024 - 2031, USD Million
  • TABLE 83 South Africa Degenerative Disc Disease Treatment Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 84 South Africa Degenerative Disc Disease Treatment Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 85 South Africa Degenerative Disc Disease Treatment Market by Drugs, 2020 - 2023, USD Million
  • TABLE 86 South Africa Degenerative Disc Disease Treatment Market by Drugs, 2024 - 2031, USD Million
  • TABLE 87 South Africa Degenerative Disc Disease Treatment Market by End Use, 2020 - 2023, USD Million
  • TABLE 88 South Africa Degenerative Disc Disease Treatment Market by End Use, 2024 - 2031, USD Million
  • TABLE 89 South Africa Degenerative Disc Disease Treatment Market by Treatment Type, 2020 - 2023, USD Million
  • TABLE 90 South Africa Degenerative Disc Disease Treatment Market by Treatment Type, 2024 - 2031, USD Million
  • TABLE 91 Nigeria Degenerative Disc Disease Treatment Market, 2020 - 2023, USD Million
  • TABLE 92 Nigeria Degenerative Disc Disease Treatment Market, 2024 - 2031, USD Million
  • TABLE 93 Nigeria Degenerative Disc Disease Treatment Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 94 Nigeria Degenerative Disc Disease Treatment Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 95 Nigeria Degenerative Disc Disease Treatment Market by Drugs, 2020 - 2023, USD Million
  • TABLE 96 Nigeria Degenerative Disc Disease Treatment Market by Drugs, 2024 - 2031, USD Million
  • TABLE 97 Nigeria Degenerative Disc Disease Treatment Market by End Use, 2020 - 2023, USD Million
  • TABLE 98 Nigeria Degenerative Disc Disease Treatment Market by End Use, 2024 - 2031, USD Million
  • TABLE 99 Nigeria Degenerative Disc Disease Treatment Market by Treatment Type, 2020 - 2023, USD Million
  • TABLE 100 Nigeria Degenerative Disc Disease Treatment Market by Treatment Type, 2024 - 2031, USD Million
  • TABLE 101 Rest of LAMEA Degenerative Disc Disease Treatment Market, 2020 - 2023, USD Million
  • TABLE 102 Rest of LAMEA Degenerative Disc Disease Treatment Market, 2024 - 2031, USD Million
  • TABLE 103 Rest of LAMEA Degenerative Disc Disease Treatment Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 104 Rest of LAMEA Degenerative Disc Disease Treatment Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 105 Rest of LAMEA Degenerative Disc Disease Treatment Market by Drugs, 2020 - 2023, USD Million
  • TABLE 106 Rest of LAMEA Degenerative Disc Disease Treatment Market by Drugs, 2024 - 2031, USD Million
  • TABLE 107 Rest of LAMEA Degenerative Disc Disease Treatment Market by End Use, 2020 - 2023, USD Million
  • TABLE 108 Rest of LAMEA Degenerative Disc Disease Treatment Market by End Use, 2024 - 2031, USD Million
  • TABLE 109 Rest of LAMEA Degenerative Disc Disease Treatment Market by Treatment Type, 2020 - 2023, USD Million
  • TABLE 110 Rest of LAMEA Degenerative Disc Disease Treatment Market by Treatment Type, 2024 - 2031, USD Million
  • TABLE 111 Key Information - Medtronic PLC
  • TABLE 112 Key Information - AstraZeneca PLC
  • TABLE 113 Key Information - Pfizer, Inc.
  • TABLE 114 Key Information - Novartis AG
  • TABLE 115 Key Information - Eli Lilly And Company
  • TABLE 116 Key Information - Spine Wave Inc.
  • TABLE 117 Key Information - B. Braun Melsungen AG
  • TABLE 118 Key Information - DiscGenics, Inc.
  • TABLE 119 Key Information - Spine BioPharma Inc.
  • TABLE 120 Key Information - Stryker Corporation
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!